Gene Query: KITLG

Dataset Description Geneva Score
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 227.52
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 182.12
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 154.44
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 118.1
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 85.31
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 79.63
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 79.63
ARID1A regulates condensin II distribution and chromosomal partition 77.84
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 77.84
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 77.76
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 69.63
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 67.05
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 64.73
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 64.73
WRN knockout effects upon gene expression in SW48 and OVK18 63.8
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 63.3
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 62.92
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 60.86
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 58.62
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 54.57
Regionally specified human pluripotent stem cell-derived astrocytes 54.01
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 51.48
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 51.13
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 51.13
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 50.13
Transcriptome analysis of kidney organoids 49.27
Paxillin regulates genomic networks in prostate cancer [LNCaP] 48.57
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 48.04
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 47.67
RNA sequencing analysis of selumetinib-resistant CRC cells lines 47.33
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 47.17
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 47.14
Transcriptional profiling of LS1034 cells treated with tepoxalin 46.55
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 44.02
TFAP2C signalling in human fibroblasts 43.86
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 43.62
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 42.57
RNA-seq of human aneuploid cell lines with Trisomy 21 41.9
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 41.84
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 41.8
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 41.4
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 41.07
Functional role of SLIT2 and ROBO1 in trophoblasts 40.77
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 40.73
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 40.44
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 40.03
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 39.47
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 39.47
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 38.31
Disruption of the exocyst induces podocyte loss and dysfunction 38.27
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 37.86
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 37.8
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 37.51
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 37.16
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 37.02
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 36.26
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 36.21
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 36.21
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 35.86
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 35.41
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 34.28
Role of CD133 molecule in WNT response and renal repair 34.11
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 33.96
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 33.37
Regulation of highly expressed hCINAP on translatome 33.15
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 32.97
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 32.84
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 32.3
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 32.1
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 31.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 31.78
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 31.78
Tumor exosome integrins determine organotropic metastasis 31.35
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 31.09
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 29.95
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 29.95
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 29.88
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 29.87
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 29.7
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 29.62
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 29.4
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 29.39
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 29.22
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 28.8
MARCKS and lnc-MARCKS act as inflammation regulators 28.21
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 27.74
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 27.74
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 27.64
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 27.32
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 26.98
TGF-β regulation of miRNA expression in pancreatic cancer 26.88
Nutritional control of protein translation 26.88
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 26.85
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 26.8
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 26.65
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 26.56
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 26.46
MYCL and EP400 are required for Max and MCPyV mediated gene activation 26.08
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 26.02
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 26.02
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 25.8
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 25.61
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 25.57
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 25.51
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 25.43
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 25.16
Differential analysis of gene regulation at transcript resolution by RNA-Seq 25.16
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 25.15
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 24.82
UBC9 knockdown in bladder cancer T24 cell lines 24.68
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 24.5
Ectoderm specification of H1 human embryonic stem cells 24.46
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 24.46
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 24.45
Neurofibroma 24.45
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 24.42
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 24.39
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 24.31
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 24.14
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 24.1
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 24.1
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 24.07
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 23.95
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 23.93
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 23.67
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 23.64
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 23.54
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 23.54
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 23.42
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 23.27
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 23.2
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 23.2
Finding missing proteins from epigenetically manipulated human cells 22.75
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 22.72
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 22.54
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 22.35
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 22.27
FOXD3 is a novel tumor suppressor in lung cancer 22.23
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 22.12
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 22.08
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 22.07
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 22.07
High-throughput sequencing of PROMPT-enriched samples. 22.06
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 21.97
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 21.83
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 21.55
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 21.53
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 21.53
Regulation of protein translation during mitosis 21.49
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 21.37
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 21.34
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 21.34
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 21.03
Comparing gene expression in iPSC derived RPE from control and AMD donors 20.94
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 20.9
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 20.9
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 20.82
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 20.82
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 20.63
Genes significantly down or Up-regulated upon RNF219 knockdown 20.17
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.15
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 20.07
Effect of from Human Umbilical Vein Endothelial Cells 19.88
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 19.85
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 19.77
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 19.77
R430: A potent inbibitor of DNA and RNA viruses 19.75
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 19.69
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 19.57
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 19.27
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 18.97
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 18.96
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 18.77
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 18.73
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 18.66
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 18.59
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 18.49
PNET animal model: new insights (II) 18.46
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 18.36
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 18.23
RNA-seq differential expression studies: more sequence, or more replication? 18.21
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 18.17
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 18.11
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 18.09
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 18.02
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 17.98
Differential expression of genes in AD169-infected MRC5. 17.9
ARID1A and ARID1B loss in HCT116 and TOV21G cells 17.67
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 17.63
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 17.63
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 17.45
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 17.45
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 17.36
RNA-seq analysis of RALD iPSCs after in vitro differentiation 17.2
GATA3-mediated chromatin reprogramming in breast cancer cells 17.18
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 17.1
A549 cell transcriptome responses to infection with H7N9 influenza virus 17.01
High level DNA repair gene expression in human ES cells 16.89
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 16.87
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 16.84
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 16.84
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 16.66
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 16.63
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 16.6
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 16.59
Gene expression analysis of dengue-infected cells 16.58
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 16.55
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 16.45
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 16.38
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 16.34
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 16.34
MCF-7 as a model for functional analysis of breast cancer risk variants 16.32
Expression data from miR340 overexpressing human A549 cells 16.3
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.25
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 16.15
TGF-β promotes genomic instability after loss of RUNX3 16.04
Identification of long noncoding RNAs regulated by p53 16.02
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 15.97
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 15.97
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 15.91
Examining serotonergic neuron differentiation from human iPSCs 15.87
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 15.86
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 15.86
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 15.51
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 15.49
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 15.47
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 15.45
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 15.45
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 15.38
Transcriptome profiling of 5 human adenocarcinoma cell lines 15.34
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 15.33
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 15.27
Molecular Mechanisms of Endothelial Hyperpermeability 15.17
Characterization of parental and rociletinib-resistant derived H1975 cell lines 15.16
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 15.16
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 15.15
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 15.15
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 14.98
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 14.9
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 14.89
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 14.78
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 14.77
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 14.7
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 14.6
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 14.6
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 14.56
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 14.56
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 14.56
High-efficiency RNA-based reprogramming of human primary fibroblasts 14.54
Active translatome profiling with RiboLace in MCF7 cells 14.52
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 14.5
Electronic cigarettes 14.46
Aneuploidy triggers an immune response 14.39
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 14.39
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 14.37
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 14.37
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 14.34
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 14.14
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 14.08
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 14.08
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.06
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 14.01
Illumina Total RNA-seq in HeLa 14.0
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 13.93
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 13.82
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 13.81
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 13.73
Gene profiling of human adult and pediatric liver cancer cells 13.73
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 13.62
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 13.58
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 13.57
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 13.56
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 13.53
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 13.52
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 13.52
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 13.41
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 13.41
The role of the Calcium-Sensing receptor in colorectal cancer 13.41
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 13.38
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 13.33
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 13.29
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 13.25
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 13.2
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 13.16
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 13.16
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 13.16
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 12.96
Toxoplasma gondii infection of human retinal pigment epithelial cells 12.66
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 12.63
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 12.55
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 12.53
Selective expression of long non-coding RNAs in a breast cancer cell progression model 12.45
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 12.45
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 12.4
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 12.38
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 12.25
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 12.24
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 12.09
ARS2 is a general suppressor of pervasive transcription [RNAseq] 12.05
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 12.04
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 12.03
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 12.03
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 11.9
Transcriptome analysis of BAP1 knockout and restoration 11.9
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 11.86
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 11.85
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 11.85
RNA-seq analysis to identify the genes regulated by p53-SET interplay 11.83
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 11.77
RNA Seq of HMVEC under hypoxia 11.74
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 11.74
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 11.56
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 11.44
Postnatal lipids drive hepatocyte maturation 11.43
The transcriptome effect of overexpressing EZH2 in MCF7 11.21
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.07
FGF2 regulation of gene expression in stable inducible Neurons 10.86
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 10.85
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 10.85
Splicing and epigenetic factors jointly regulate epidermal differentiation 10.82
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 10.8
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 10.8
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 10.7
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 10.7
Interphase condensins regulate ligand-depedent enhancer activation 10.4
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 10.4
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 10.36
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 10.26
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 10.24
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 9.93
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 9.9
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 9.66
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 9.66
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.6
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.54
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.54
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 9.53
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 9.32
Transciptomic profiling of human fetal lung samples 9.3
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 9.19
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 9.14
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 8.94
RNAseq of cell lines with knocked in ESR1 mutations 8.91
Identification of differentially expressed genes between senescence and senescence bypass cells 8.9
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 8.86
Noncoding regions are the main source of targetable tumor-specific antigens 8.83
JAK dependent survival of ALK- ALCL 8.79
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 8.71
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 8.66
Reprogrammed myeloid cell transcriptomes in NSCLC 8.64
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 8.62
PRDM1 inhibits proliferation of human colon cancer organoids 8.59
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 8.43
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 8.43
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.42
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 8.31
Genome-wide discovery of human splicing branchpoints [RNAse] 8.29
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.29
Genome-wide discovery of human splicing branchpoints 8.17
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 8.14
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 8.1
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 8.05
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.04
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 8.03
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 8.03
Hepatitis C virus functionally sequesters miR-122 7.85
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.85
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.81
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.81
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 7.69
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.53
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 7.37
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 7.19
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 6.84
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.8
Molecular analysis of renal cell carcinoma with unclassfied histology 6.8
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 6.78
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.74
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 6.74
p53 activity results in DNA replication fork processivity 6.65
The circadian transcriptional landscape in primary human mammary epithelial cells 6.48
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 6.46
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 6.46
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.46
RNAseq of IL-36 stimulated primary human keratinocytes 6.45
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 6.35
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.34
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 6.14
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.99
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 5.98
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.77
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.75
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.75
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.62
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 5.51
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 5.51
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 5.32
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 5.23
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 5.21
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 5.21
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.21
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.21
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.21
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 5.2
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 5.14
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 5.14
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.1
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.09
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 5.03
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 4.95
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 4.95
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 4.93
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 4.88
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.79
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.79
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.79
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.78
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.77
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.73
mRNA recovered upon RNF219 IP. [RNA-IP] 4.71
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.25
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.25
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.24
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.24
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.2
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.19
SF3B1 Degron knockdown RNA-seq 4.01
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.96
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.91
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 3.9
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.84
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 3.75
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.7
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.7
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 3.68
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 3.66
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.58
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.55
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.52
Interaction between mitoNEET and NAF-1 in cancer cells 3.45
Fbxo32 mediated gene expression program underlies EMT and metastasis 3.28
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.27
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.27
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.24
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 3.18
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 3.18
RNA sequencing of human pancreatic cancer cell lines 3.17
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 3.11
Effects of transcription on genome - nuclear lamina interactions 3.11
6mer seed toxicity in tumour suppressive microRNAs 3.02
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.97
Derivation and differentiation of haploid human embryonic stem cells 2.95
p63 controls the enhancer landscape during keratinocyte differentiation 2.79
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.63
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.63
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 2.62
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.5
Gene expression profile of CRC-derived HILEC 2.48
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.42
BMS-470539 on human synovial fibroblasts 2.25
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 2.24
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.14
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.92
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 1.91
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.78
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.67
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.62
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.58
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.46
Preclinical model of obesity and ER-positive breast cancer 1.45
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.45
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 1.31
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.26
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.26
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 1.04
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 1.02
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.99
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 0.9
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 0.9
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.9
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.82
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.77
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.76
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.65
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.57
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.48
FOXP2's impact on the primate transcriptome 0.48
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.37
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.32
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.24
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.23
Identification of the role of polydom in neurofibromas 0.21
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.13
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.13
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.02
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.01
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation